News Website

Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer - Oncology Nurse Advisor

Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer Oncology Nurse Advisor

Published: Dec. 23, 2024, 5 p.m.

Read Full Article

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone Medpage Today

Published: June 5, 2024, 7 a.m.

Read Full Article

Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer - AJMC.com Managed Markets Network

Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer AJMC.com Managed Markets Network

Published: May 9, 2024, 7 a.m.

Read Full Article

KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology

KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology

Published: Jan. 5, 2024, 8 a.m.

Read Full Article

Latest Articles

Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer - Oncology Nurse Advisor

ASCO Reading Room | Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone - Medpage Today

Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer - AJMC.com Managed Markets Network

KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology

Subscribe to Our Newsletter